Dotmatics, a scientific informatics software provider headquartered in Hertfordshire, has raised investment from Scottish Equity Partners (SEP).
The terms of the deal are not being disclosed, but the investment is being made by SEP V, a £260m growth stage fund which typically invests up to £25m.
Founded in 2005, Dotmatics has a broad range of clients operating across industries such as pharmaceuticals, biotech, academia, food, beverage, oil and gas.
According to the company, the funding will be used to invest in product innovation as well as to expand operations in each of the firm’s key geographies.
Stephen Gallagher, CEO of Dotmatics, commented: “We have grown rapidly and organically since inception and are pleased to have secured SEP as investors given the firm’s considerable software and health sector experience and their record of scaling companies.
“The funding will enable us to continue our aggressive trajectory in providing chemistry solutions, further expansion into biologics and increase our investment into customer support through strategic hires in application science product development and professional services.”
Matillion raises $35m in Series C funding round
Operating from offices in London, Glasgow and Edinburgh, SEP makes equity investments across a range of sectors, including software, consumer internet, e-commerce, healthcare and tech-enabled service businesses.
Keith Davidson, a partner at SEP, added: “Dotmatics is a fast growing and capital efficient SaaS business, with an excellent reputation in the scientific research informatics market.
“The company has a strong focus on innovation and providing customers with first class scientific solutions and support. We have watched the company expand its customer base significantly over the course of the last few years and look forward to supporting its future growth plans.”
Check out our UK tech investment tracker for the latest industry deals.